Omeros Corporation

Healthcare · Biotechnology

20.10$ -0.2% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Omeros Corporation (OMER) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 287 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet OMER
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	73	67	58	60	126	116	89	106	76	96	101	90	91	137	118	71	227	181	161	145	123	419	369	346	458	591	560	527	493	378	437	356	313	277	235	201	186	326	286	287
Current Assets	61	60	51	53	118	108	79	97	66	90	77	66	64	104	86	39	196	151	132	112	91	248	210	193	289	443	417	389	351	218	281	203	165	134	96	70	72	216	180	185
Cash	10	2.2	1.3	3.4	1.0	3.4	1.2	2.9	2.8	5.9	4.1	4.0	8.9	3.1	7.1	2.0	21	11	9.0	13	7.4	101	9.0	14	146	11	3.8	6.6	31	7.1	1.8	2.1	1.5	3.4	4.3	1.9	2.4	9.7	1.9	2.0
Cash & Short-Term Investments	47	45	34	30	87	84	73	88	55	60	47	32	27	61	54	16	154	135	100	74	50	157	142	123	221	195	371	341	310	–	230	159	123	90	52	29	36	172	135	132
Receivables	10	12	13	19	25	17	0.2	1.5	2.3	23	25	29	30	35	24	16	37	3.8	25	31	34	82	60	58	62	242	39	11	36	6.7	37	38	36	37	5.6	34	32	36	38	21
Inventory	1.4	1.1	1.0	0.9	0.8	0.4	0.2	0.2	0.2	53	0.7	1.2	1.2	48	1.2	1.9	1.5	115	1.2	1.0	0.7	0.0	0.0	-44	-48	–	–	–	–	–	–	–	–	–	–	–	–	–	0.2	0.8
Property, Plant & Equipment	1.2	1.2	1.2	1.4	1.8	2.1	2.1	2.4	2.5	3.8	4.5	4.2	3.8	3.8	3.4	3.1	3.0	28	27	32	31	30	24	25	24	23	–	22	–	–	–	–	–	–	–	–	–	–	–	–
Goodwill	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Intangible Assets	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Total Liabilities	96	105	107	115	116	119	118	163	165	-4.2	222	220	231	246	250	232	314	302	383	392	386	395	374	378	504	505	505	507	507	403	509	481	468	460	449	429	406	447	350	338
Current Liabilities	16	16	17	25	25	26	25	24	25	37	45	41	47	55	58	38	48	37	43	48	43	52	35	39	40	136	139	144	147	53	59	59	56	80	83	86	81	78	59	95
Short-Term Debt	0.2	0.2	0.2	0.3	0.4	0.5	0.5	0.6	0.6	0.9	2.6	2.6	3.1	3.5	3.6	3.7	3.8	3.8	3.8	4.9	5.1	5.3	3.9	4.1	4.4	99	102	104	100	–	24	25	5.8	27	54	23	23	23	26	38
Accounts Payable	4.0	2.5	2.4	2.6	3.7	6.7	10	12	8.8	6.3	7.1	6.3	9.7	5.3	13	8.5	7.0	4.2	11	9.5	10	13	7.3	11	17	6.0	6.4	9.6	5.9	7.7	6.2	6.5	7.7	5.9	4.4	8.8	12	4.8	5.4	6.3
Long-Term Debt	70	80	81	82	83	84	85	130	132	149	151	153	156	158	161	163	233	236	312	313	313	313	314	314	315	221	221	222	222	213	213	191	189	167	159	151	160	209	137	97
Shareholders' Equity	-23	-37	-48	-55	9.2	-2.8	-29	-56	-89	650	-121	-130	-140	-109	-132	-161	-87	-873	-222	-246	-263	24	-4.9	-33	-46	86	55	21	-14	-25	-71	-125	-154	-183	-214	-229	-220	-121	-63	-51
Retained Earnings	-450	-470	-485	-499	-507	-523	-553	-587	-627	650	-674	-689	-705	-735	-764	-797	-835	-873	-912	-941	-964	-683	-716	-747	-764	-636	-669	-707	-744	-754	-791	-847	-879	-910	-944	-969	-1,000	-914	-858	-844
Shares Outstanding	41	43	44	44	46	48	48	48	49	49	49	49	49	51	54	55	58	62	62	62	63	63	63	63	63	63	63	63	63	61	59	58	58	58	58	59	66	64	90	90

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings